U.S. Auto Stock News

UBS recently named Cigna Group as a top healthcare pick, arguing that concerns around pharmacy benefit manager reform have largely been absorbed and that the company’s move to a rebate-free model has improved earnings visibility. The analysts also highlighted Cigna’s limited exposure to government reimbursement, its discount relative to peers, and the potential for share buybacks as key supports for the investment case. We’ll now examine how UBS’s view of Cigna as undervalued with improved...

Plains GP Holdings filed a new shelf registration for its Class A common shares. The filing gives the company flexibility to issue new equity securities in the future. The move is a material corporate action that can affect funding plans and existing shareholders. Plains GP Holdings (NasdaqGS:PAGP) last closed at $24.42, with the shares showing returns of 2.8% over the past week and 8.3% over the past month. Over longer periods, the stock has returns of 25.8% year to date and 24.1% over the...

Samsung and Advanced Micro Devices (NasdaqGS:AMD) signed a memorandum of understanding covering HBM4 memory supply and possible future foundry cooperation for AI chips. The agreement centers on Samsung providing HBM4 for AMD's MI455X AI GPUs, which are planned for its Helios rack scale AI infrastructure. The partnership points to tighter integration across memory and manufacturing for upcoming generations of AI hardware. AMD enters this announcement with a share price of $196.04 and a 1...

Damora Therapeutics recently overhauled its leadership, appointing former Arcus Biosciences executive Jennifer Jarrett as President and Chief Executive Officer and adding industry veterans Cameron Turtle and Mike Landsittel to its Board, while several directors resigned. This reshaping of the executive team brings together extensive biopharma operating, deal-making and capital markets experience, potentially influencing how Damora pursues future partnerships, financing and commercialization...

Cintas (CTAS) is back on investors’ radar after releasing third quarter results and lifting its fiscal 2026 outlook, including guidance for annual revenue of about US$11.21b to US$11.24b. See our latest analysis for Cintas. The guidance lift comes after a weak stretch for the share price, with a 30 day share price return of 16.14% and a year to date share price return showing an 8.77% decline. However, the 3 year total shareholder return of 50.27% and 5 year total shareholder return of 99.52%...

Agios Pharmaceuticals recently disclosed that, following a pre-supplemental New Drug Application meeting, it will seek U.S. accelerated approval for mitapivat in sickle cell disease and has already submitted a proposal for the required confirmatory trial, which is not expected to alter its previously issued operating expense guidance. An interesting aspect for investors is that the FDA has asked Agios to run a confirmatory trial with a new primary endpoint informed by RISE UP data and...

Cimpress (CMPR) has put a new capital return plan in focus, announcing a share repurchase program of up to US$200 million shortly after its previous buyback expired and its removal from the NASDAQ Internet Index. See our latest analysis for Cimpress. At a share price of US$72.75, Cimpress has delivered a 90 day share price return of 9.25% and a 1 year total shareholder return of 59.05%. The new US$200 million buyback plan keeps capital allocation in focus after its removal from the NASDAQ...

Recent share performance and business snapshot Celsius Holdings (CELH) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months while the underlying business continues to generate revenue and earnings. The company operates in functional energy and hydration drinks, reporting US$2,515.3m in revenue and US$63.8m in net income, primarily from North America, and carries a market value of about...

Investors may be wondering if Akamai Technologies at around US$110 a share still offers value, or if most of the easy gains are already on the table. The stock closed at US$110.22, with a 3.7% decline over the last 7 days, a 12.0% gain over 30 days, 29.5% year to date, 36.9% over 1 year, 41.5% over 3 years, and 6.1% over 5 years. This gives you a wide range of recent return experiences to weigh up. Recent coverage has focused on Akamai's role as a key infrastructure player for content...

Recent share performance and business snapshot Occidental Petroleum (OXY) has drawn investor attention after a recent share price move, with the stock last closing at $66.24, set against a value score of 2 and an intrinsic discount estimate of 42.71%. See our latest analysis for Occidental Petroleum. The recent 1-month share price return of 24.79% and 90-day share price return of 59.77% point to strong positive momentum. The 1-year total shareholder return of 37.10% and 5-year total...

In recent weeks, gold prices have swung as easing U.S.–Iran tensions, a stronger U.S. dollar and profit‑taking offset concerns about the U.S.’s roughly US$42.00 trillion net fiscal deficit and rising Treasury yields, which together keep gold’s role as a hedge in focus for investors. As the world’s largest gold producer, Newmont has sat at the center of these shifting speculative flows into and out of gold, with its cost efficiencies and dividend profile drawing investors who are reassessing...

Over the last 7 days, the United States market has dropped 3.5%, yet it has seen a rise of 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these growth opportunities.

AbbVie’s Allergan Aesthetics unit is running its fourth annual CoolMonth promotion in April 2026, offering new patients discounts on CoolSculpting treatments. The company highlighted new aesthetics data at the American Academy of Dermatology meeting, including a next generation neurotoxin candidate. AbbVie reported emerging trends such as GLP-1 users entering the aesthetics segment and patient concerns about cost and unnatural looking results. For NYSE:ABBV, this CoolMonth campaign...

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year with anticipated earnings growth of 15% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading below their estimated worth can provide opportunities for investors seeking value amidst broader market trends.

If you are wondering whether AT&T's current price really reflects what you are getting as a shareholder, you are asking the right question. AT&T recently closed at US$28.78, with returns of 0.1% over 7 days, 2.7% over 30 days, 17.2% year to date and 6.2% over the last year. This gives you a useful starting point for judging value. Recent coverage around AT&T has focused on its role as a major U.S. telecom provider and how it fits into long term connectivity trends. This context helps frame...

S&P Global has appointed Firdaus Bhathena as Executive Vice President and Chief Technology and Transformation Officer, while also facing shareholder proposals on special meeting rights and charitable giving oversight ahead of its May 20, 2026 annual meeting. This combination of a senior technology hire and active governance-focused shareholders highlights how digital transformation and investor scrutiny are shaping S&P Global’s next phase. We’ll now examine how Bhathena’s technology and...

Over the last 7 days, the United States market has experienced a 3.5% decline, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may offer resilience amid market fluctuations.

Progressive (NYSE:PGR) has completed two major fixed income offerings totaling more than $1.4b in senior unsecured notes. The new notes mature in 2031 and 2036, adding longer dated debt to the company’s capital structure. AM Best assigned an 'a' (Excellent) credit rating and a stable outlook to these new unsecured notes. Progressive, trading at $201.39, comes into this debt issuance with a mixed share price record, including a 24.2% decline over the past year and gains of 51.9% over three...

Philip Morris International (NYSE:PM) has released its Value Report 2025, outlining updated priorities across its smoke free transition. The company has also introduced its Value Plan 2030+, setting new long term focus areas for consumer health impact, climate, biodiversity, and workforce well being. These disclosures expand on prior transformation efforts by linking sustainability goals with business planning and capital allocation over the coming years. For investors following NYSE:PM,...

Over the last 7 days, the United States market has dropped 3.5%, but it has seen a rise of 14% over the past year, with earnings projected to grow by 15% annually in coming years. In light of these conditions, identifying stocks with strong financial health and growth potential is crucial for investors seeking opportunities beyond mainstream options. Penny stocks, though an outdated term, still represent a niche investment area that can offer surprising value and potential returns when backed...

Why WisdomTree is on investors’ radar today WisdomTree (WT) has attracted fresh attention after recent share price swings, with a month return of 18.6% decline contrasting with a 12.1% gain over the past 3 months and 57.6% total return over the past year. See our latest analysis for WisdomTree. The recent 18.6% 1 month share price decline contrasts with double digit 3 month gains and a strong multi year total shareholder return. This may indicate a pause in momentum rather than a clear shift...

McCormick (NYSE:MKC) is in advanced talks to combine with Unilever's food business, signaling a potential landmark merger in the global packaged food sector. The deal discussions are described as being in a late stage, with an announcement viewed as relatively near term. The combination would reshape McCormick's brand mix and global footprint, creating a much larger player in spices, seasonings, and pantry staples. For investors watching McCormick, the timing of these talks comes after a...

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can be a rewarding strategy for investors seeking potential opportunities.

Over the last 7 days, the United States market has experienced a 3.5% drop, although it has shown resilience with a 14% rise over the past year and an earnings growth forecast of 15% annually. In this context, dividend stocks that offer consistent payouts and potential for long-term appreciation can be attractive options for investors seeking stability amidst fluctuating market conditions.